BWM
AGN

Baystate Wealth Management’s Allergan plc AGN Stock Holding History

Baystate Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-99
Closed -$18K – 769
2020
Q1 		$18K Hold
99
– – ﹤0.01% 301
2019
Q4 		$19K Buy
99
+72
+267% +$13K ﹤0.01% 329
2019
Q3 		$5K Buy
27
+1
+4% +$163 ﹤0.01% 430
2019
Q2 		$4K Sell
26
-4
-13% -$554 ﹤0.01% 454
2019
Q1 		$4K Sell
30
-2
-6% -$290 ﹤0.01% 460
2018
Q4 		$5K Hold
32
– – ﹤0.01% 445
2018
Q3 		$6K Hold
32
– – ﹤0.01% 430
2018
Q2 		$6K Buy
32
+26
+433% +$4.17K ﹤0.01% 440
2018
Q1 		$1K Buy
6
+2
+50% +$335 ﹤0.01% 654
2017
Q4 		$1K Sell
4
-170
-98% -$30.5K ﹤0.01% 644
2017
Q3 		$35K Sell
174
-93
-35% -$21.6K 0.01% 220
2017
Q2 		$66K Sell
267
-79
-23% -$18.6K 0.01% 154
2017
Q1 		$82K Buy
346
+172
+99% +$40.1K 0.02% 128
2016
Q4 		$38K Buy
+174
New +$36K 0.01% 169

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Baystate Wealth Management's AGN Position: Q2 2020 in Review

Baystate Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 99 shares — an estimated $18K sold.

Baystate Wealth Management first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $82K in Q1 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Baystate Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Baystate Wealth Management sold 99 Allergan plc shares in Q2 2020, an estimated $18K.
  • Baystate Wealth Management first reported a position in Allergan plc in Q4 2016 and held it in 14 quarters.
  • Baystate Wealth Management's Allergan plc position peaked at $82K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Baystate Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.